Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

InflaRx (IFRX) Invested Capital (2016 - 2026)

InflaRx's Invested Capital history spans 10 years, with the latest figure at $43.2 million for Q1 2026.

  • On a quarterly basis, Invested Capital fell 41.73% to $43.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $43.2 million, a 41.73% decrease, with the full-year FY2025 number at $48.4 million, down 26.29% from a year prior.
  • Invested Capital hit $43.2 million in Q1 2026 for InflaRx, down from $48.4 million in the prior quarter.
  • Over the last five years, Invested Capital for IFRX hit a ceiling of $135.7 million in Q2 2023 and a floor of $43.2 million in Q1 2026.
  • Historically, Invested Capital has averaged $86.9 million across 5 years, with a median of $88.5 million in 2024.
  • Biggest five-year swings in Invested Capital: rose 27.92% in 2023 and later crashed 44.18% in 2024.
  • Tracing IFRX's Invested Capital over 5 years: stood at $90.1 million in 2022, then rose by 22.45% to $110.4 million in 2023, then crashed by 40.54% to $65.6 million in 2024, then decreased by 26.29% to $48.4 million in 2025, then fell by 10.72% to $43.2 million in 2026.
  • Business Quant data shows Invested Capital for IFRX at $43.2 million in Q1 2026, $48.4 million in Q4 2025, and $53.0 million in Q3 2025.